Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Medios AG
  6. News
  7. Summary
    ILM1   DE000A1MMCC8

MEDIOS AG

(ILM1)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

PRESS RELEASE: Medios AG holds successful 2021 Annual General Meeting - Focus on Corporate Governance

06/10/2021 | 09:35am EDT
DGAP-News: Medios AG / Key word(s): AGM/EGM 
Medios AG holds successful 2021 Annual General Meeting - Focus on Corporate Governance 
2021-06-10 / 15:33 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Press Release 
Medios AG holds successful 2021 Annual General Meeting - Focus on Corporate Governance 
  . Supervisory Board extension: Dr. Anke Nestler elected as fourth member 
  . Remuneration systems for Executive Board and Supervisory Board approved and new Authorized Capital 2021 created for 
    growth financing 
  . Audit Committee and Remuneration and Nomination Committee formed 
Berlin, 10 June 2021 - Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, 
successfully held its virtual Annual General Meeting 2021 today. All resolutions on the agenda items were passed with a 
clear majority. In total, around 74% of the share capital was represented. The agenda items included, among others, 
Corporate Governance issues such as the extension of the Supervisory Board from three to four members and the approval 
of the future remuneration systems for the Executive Board and Supervisory Board. In addition, the Annual General 
Meeting approved the creation of new Authorized Capital 2021. All voting results are available on the Medios AG website 
at https://medios.ag/en/investor-relations/annual-general-meeting. Following the Annual General Meeting, the 
Supervisory Board appointed an Audit Committee and a Remuneration and Nomination Committee from among its members at 
its first meeting as a four-member body. These committees are two-member, so-called non-resolutions committees. 
Matthias Gaertner, CEO and CFO of Medios AG: "We would like to thank our shareholders for their great trust. With the 
measures resolved by the Annual General Meeting and the Supervisory Board, we are sending a clear signal in terms of 
good Corporate Governance. Today's approval of all resolutions lays the foundation to successfully continue our growth 
path also through further acquisitions and to further play an important role in the Specialty Pharma sector as a 
leading and strong partner." 
Important resolutions of the Annual General Meeting 
With the extension of the Supervisory Board, Medios' organization will be even more closely aligned with the company's 
dynamic growth. Dr. Anke Nestler, a recognized financial expert, was elected as a new member of the Supervisory Board. 
Dr. Yann Samson, Chairman of the Supervisory Board of Medios AG: "We are pleased to welcome Dr. Nestler as a new member 
of the Supervisory Board and Chairwoman of the Audit Committee. We are convinced that with her many years of experience 
in complex financial consulting and reporting issues, she will be able to contribute valuable expertise to our 
committees." 
The future remuneration system for the Executive Board not only implements legal requirements, but is also intended to 
promote long-term and sustainable corporate development and take into account the interests of investors. In 
particular, the remuneration system includes variable, performance-related remuneration components with a long-term 
stock option plan and short-term bonuses depending on the company's success and sustainability goals (ESG). 
The new Authorized Capital 2021 is particularly intended to enable Medios to cover any financing requirements quickly 
and flexibly in order to promote Medios' further growth while protecting its equity base - for example in the event of 
acquisitions. 
As in the previous year, the Annual General Meeting 2021 was held as a virtual event due to the Corona-related contact 
restrictions. The Executive Board explained the business development in the 2020 financial year and in the first 
quarter of 2021 as well as the plans and targets for the current financial year. It also confirmed the forecast for the 
current financial year. 
=------------------ 
About Medios AG 
Medios AG is the leading provider of Specialty Pharma solutions in Germany. As a competence partner and expert, Medios 
covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of 
patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies. 
Medios AG is Germany's first listed Specialty Pharma company and member of the SDAX selection index (Prime Standard) 
(ISIN: DE000A1MMCC8). 
www.medios.ag 
Contact 
Claudia Nickolaus 
Head of Investor & Public Relations 
Medios AG 
Heidestraße 9 | 10557 Berlin | Germany 
P +49 30 232 566 800 
c.nickolaus@medios.ag 
www.medios.ag 
Nikolaus Hammerschmidt 
Senior Consultant Investor & Public Relations 
Kirchhoff Consult AG 
Borselstraße 20 | 22765 Hamburg | Germany 
P +49 40 609 186 18 
nikolaus.hammerschmidt@kirchhoff.de 
www.kirchhoff.de 
Disclaimer 
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future 
results may significantly deviate from currently expected results, specifically due to various risk factors and 
uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, 
uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no 
responsibility whatsoever for updating the forward-looking statements contained in this notification. 
=---------------------------------------------------------------------------------------------------------------------- 
2021-06-10 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      Medios AG 
              Heidestraße 9 
              10557 Berlin 
              Germany 
Phone:        +49 30 232 566 - 800 
Fax:          +49 30 232 566 - 801 
E-mail:       ir@medios.ag 
Internet:     www.medios.ag 
ISIN:         DE000A1MMCC8 
WKN:          A1MMCC 
Indices:      SDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf 
EQS News ID:  1206678 
 
End of News   DGAP News Service 
=------------ 

1206678 2021-06-10

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1206678&application_name=news 
 

(END) Dow Jones Newswires

June 10, 2021 09:34 ET (13:34 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
DJ INDUSTRIAL -0.21% 33874.24 Delayed Quote.10.91%
MEDIOS AG 0.15% 32.35 Delayed Quote.-13.64%
SDAX -0.96% 15918.24 Delayed Quote.8.86%
All news about MEDIOS AG
06/18MEDIOS AG : Preliminary announcement of the publication of financial reports acc..
EQ
06/15MEDIOS AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
06/10PRESS RELEASE : Medios AG holds successful 2021 Annual General Meeting - Focus o..
DJ
06/10MEDIOSá : holds successful 2021 Annual General Meeting - Focus on Corporate Gove..
EQ
05/12MEDIOSá : Buy rating from Berenberg
MD
05/11MEDIOSá : Warburg Research keeps its Buy rating
MD
05/11MEDIOSá : starts the 2021 financial year with a record quarter
EQ
05/11PRESS RELEASE : Medios AG starts the 2021 financial year with a record quarter
DJ
05/07MEDIOSá : Deutsche Bank reiterates its Buy rating
MD
04/19MEDIOSá : Buy rating from Deutsche Bank
MD
More news
Financials
Sales 2021 1 236 M 1 476 M 1 476 M
Net income 2021 15,8 M 18,9 M 18,9 M
Net Debt 2021 9,08 M 10,8 M 10,8 M
P/E ratio 2021 38,4x
Yield 2021 -
Capitalization 655 M 779 M 782 M
EV / Sales 2021 0,54x
EV / Sales 2022 0,45x
Nbr of Employees 307
Free-Float 71,1%
Chart MEDIOS AG
Duration : Period :
Medios AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIOS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 32,30 €
Average target price 47,75 €
Spread / Average Target 47,8%
EPS Revisions
Managers and Directors
NameTitle
Matthias A. Gńrtner Chief Executive Officer
Yann Samson Chairman-Supervisory Board
Mi Young Miehler Chief Operating Officer
Klaus Bu▀ Member-Supervisory Board
Joachim Messner Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MEDIOS AG-13.64%779
WALGREENS BOOTS ALLIANCE, INC.29.81%44 750
JD HEALTH INTERNATIONAL INC.-31.60%42 068
MCKESSON CORPORATION9.30%29 402
CARDINAL HEALTH, INC.5.83%16 448
HUADONG MEDICINE CO., LTD73.64%12 452